factor

(redirected from Tissue factor)
Also found in: Dictionary, Thesaurus, Medical, Financial, Encyclopedia, Wikipedia.
Related to Tissue factor: thrombin, Tissue factor pathway inhibitor

Factor

An event, circumstance, influence, or element that plays a part in bringing about a result.

A factor in a case contributes to its causation or outcome. In the area of Negligence law, the factors, or chain of causation, are important in determining whether liability ensues from a particular action done by the defendant.

factor

n. 1) a salesman who sells in his/her own name on behalf of others, taking a commission for services. 2) something that contributes to the result.

factor

(Commission merchant), noun agent, broker, commercial agent, delegate, deputy, envoy, interagent, manager, medium, middleman, one who sells for factorage, proctor, procurator, representative
Associated concepts: consignee, factors' lien

factor

(Ingredient), noun additive, agent, aid, aspect, cause, component, constituent, constitutive element, content, contributing force, determinant, element, elementary unit, feature, integral part, part, portion, segment, unit
See also: aspect, broker, cause, characteristic, component, constituent, dealer, deputy, determinant, element, feature, ingredient, member, part, plenipotentiary, portion, procurator, reason, represent, substitute

factor

1 a mercantile agent. An agent who is in the ordinary course of business entrusted with goods or documents of title representing goods with a view to their sale. A factor has a lien over goods entrusted to him; this lien covers any claims he may have against his principal arising out of the agency. Most factors will be mercantile agents (and have the powers of such) for the purposes of the Factors Act 1889. Under this Act, in certain circumstances a factor may pass a good title to goods entrusted to him.
2 an institution to whom a company assigns its book debts (see FACTORING).
3 in Scotland a landlord or superior's agent.
References in periodicals archive ?
TF-containing MEPs-lysates were stored at--8 [degrees]C until being assayed using an ELISA kit (Imubind Tissue Factor, American Diagnostic Inc.
Tissue factor appears to have an important role in mediating the increased thrombogenicity in persons with type 2 diabetes (Sambola et al.
ABBREVATIONS: APC = activated protein C; AT = antithrombin; C4bBP = Cob binding protein; DIC = disseminated intravascular coagulation; EC = endothelial cells; EPCR = endothelial cell protein C receptor; GAG = glycosaminoglycans; PAF = platelet activating factor; PAI-1 = plasminogen activator inhibitor-1; PARs = protease activated receptor; PC = protein C; PDGF = platelet derived growth factor; TAFI = thrombin activated fibrinolysis inhibitor; TFPI = tissue factor pathway inhibitor; TM = thrombomodulin; TNF = tumor necrosis factor; ULVWF = ultra-large multimers of von Willebrand factor.
In addition, tissue factor plays an important role in tumor progression in many types of cancers.
The disseminated microthrombi decrease tissue oxygenation, which causes organ infarction and necrosis and eventual increased release of tissue factor.
In the emerging new model, tissue factor exists on the surfaces of these smooth muscle cells, as well as on circulating immune cells, but in an inactive state," said Scripps Research Professor Wolfram Ruf.
Increases activity of coagulation inhibitors such as antithrombin (AT) and tissue factor pathway inhibitor (TFPI)
KEY WORDS: coagulation cascade, human endothelial cells, microarray, particulate matter, tissue factor.
Abnormalities of local tissue procoagulation and fibrinolysis have been described in sarcoidosis; namely, enhanced tissue factor pathway activity, increased tissue thromboplastin activity, diminished plasminogen activator activity, increased factor VII activity, decreased protein C activation, and increased thrombin-activatable fibrinolysis inhibitor.
RFVIIa combines with tissue factor (TF) in the subendothelium of damaged blood vessels to create a thrombin burst1.
a clinical-stage pharmaceutical company developing therapeutics for treatment of anemia and cancer, announced that they have entered into a research collaboration for the synthesis and development of novel peptides that mimic certain fragments of tissue factor pathway inhibitor (TFPI).

Full browser ?